We are live on ! Find out more
MGP

Metis Global Partners Portfolio holdings

AUM $4.07B
1-Year Est. Return 30.82%
This Fund
S&P 500
This Quarter Est. Return
-4.51%
1 Year Est. Return
+30.82%
3 Year Est. Return
+100.28%
5 Year Est. Return
10 Year Est. Return
AUM
$621M
AUM Growth
-$4.48M
Cap. Flow
+$35.3M
Cap. Flow %
5.69%
Top 10 Hldgs %
24.97%
Holding
556
New
22
Increased
281
Reduced
205
Closed
37

Top Buys

Rank Stock Value
1
IEUR icon
iShares Core MSCI Europe ETF
IEUR
+$3.58M
2
AAPL icon
Apple
AAPL
+$3.57M
3
MSFT icon
Microsoft
MSFT
+$2.81M
4
AMZN icon
Amazon
AMZN
+$1.96M
5
TSLA icon
Tesla
TSLA
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Financials 14.96%
3 Healthcare 14.01%
4 Consumer Discretionary 10.57%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$39.9M 6.42%
288,380
+22,726
+9% +$3.57M
MSFT icon
2
Microsoft
MSFT
$2.84T
$31.1M 5.02%
133,648
+10,656
+9% +$2.81M
AMZN icon
3
Amazon
AMZN
$2.5T
$18.4M 2.96%
162,463
+15,511
+11% +$1.96M
TSLA icon
4
Tesla
TSLA
$1.24T
$13.6M 2.19%
51,159
+6,564
+15% +$1.83M
IEUR icon
5
iShares Core MSCI Europe ETF
IEUR
$8.66B
$10.5M 1.69%
264,510
+80,542
+44% +$3.58M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$9.35M 1.51%
97,732
+1,812
+2% +$201K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$9.31M 1.5%
96,788
+3,808
+4% +$425K
UNH icon
8
UnitedHealth
UNH
$382B
$8.45M 1.36%
16,733
+1,066
+7% +$561K
JNJ icon
9
Johnson & Johnson
JNJ
$635B
$7.55M 1.22%
46,209
+2,273
+5% +$385K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$6.97M 1.12%
26,087
-452
-2% -$129K
NVDA icon
11
NVIDIA
NVDA
$5.01T
$5.76M 0.93%
474,500
+60,000
+14% +$949K
META icon
12
Meta Platforms (Facebook)
META
$1.51T
$5.67M 0.91%
41,785
+2,471
+6% +$401K
XOM icon
13
ExxonMobil
XOM
$651B
$5.51M 0.89%
63,171
-319
-0.5% -$29.1K
V icon
14
Visa
V
$677B
$5.48M 0.88%
30,848
+2,405
+8% +$489K
JPM icon
15
JPMorgan Chase
JPM
$939B
$5.43M 0.87%
51,940
+3,357
+7% +$385K
HD icon
16
Home Depot
HD
$332B
$5.21M 0.84%
18,899
+1,707
+10% +$504K
LLY icon
17
Eli Lilly
LLY
$1.07T
$4.94M 0.8%
15,276
+1,636
+12% +$518K
PG icon
18
Procter & Gamble
PG
$343B
$4.93M 0.79%
39,031
-297
-0.8% -$42.2K
ABBV icon
19
AbbVie
ABBV
$458B
$4.63M 0.75%
34,486
-306
-0.9% -$43.9K
MRK icon
20
Merck
MRK
$324B
$4.57M 0.74%
53,017
+3,291
+7% +$294K
MA icon
21
Mastercard
MA
$477B
$4.33M 0.7%
15,244
+863
+6% +$286K
PFE icon
22
Pfizer
PFE
$140B
$4.25M 0.68%
97,107
+4,783
+5% +$232K
RY icon
23
Royal Bank of Canada
RY
$291B
$4.1M 0.66%
45,518
-6,661
-13% -$639K
KO icon
24
Coca-Cola
KO
$354B
$4M 0.64%
71,404
+4,648
+7% +$289K
CVX icon
25
Chevron
CVX
$388B
$3.99M 0.64%
27,771
-1,696
-6% -$259K

Similar funds

Metis Global Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Metis Global Partners held 556 positions worth $621M, down 0.72% from $625M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metis Global Partners deployed $35.3M of net new capital in Q3 2022, opening 22 new positions and adding to 281 existing holdings. Its largest new stake was Autohome: 19,246 shares worth $554K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Royal Bank of Canada, an estimated $639K trimmed.

  • Metis Global Partners's largest Q3 2022 buy was Autohome: 19,246 shares worth $554K.
  • Metis Global Partners added most to iShares Core MSCI Europe ETF in Q3 2022, an estimated $3.58M increase.
  • Metis Global Partners's biggest Q3 2022 reduction was Royal Bank of Canada, cutting an estimated $639K.
  • Metis Global Partners fully exited DXC Technology in Q3 2022, selling an estimated $645K.
  • Metis Global Partners's ten largest holdings make up 25% of its $621M portfolio in Q3 2022.
  • Metis Global Partners opened 22 new positions and closed 37 in Q3 2022.
  • Metis Global Partners's portfolio value fell 0.72% quarter-over-quarter to $621M.

Based on Metis Global Partners's 13F filing for Q3 2022, filed 8 Nov 2022.